Navigation Links
BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update
Date:7/30/2009

-viral for influenza, and forodesine, a purine nucleoside phosphorylase (PNP) inhibitor for cutaneous T-cell lymphoma (CTCL). Utilizing crystallography and structure-based drug design, BioCryst continues to expand its portfolio of next-generation therapeutic candidates with the potential to address the unmet medical needs of patients and physicians. The Company's strategic alliances with the U.S. Department of Health and Human Services, Shionogi & Co., Ltd., Green Cross Corporation and Mundipharma International Holdings Limited validate its scientific foundation and the utility of its product candidates. For more information, please visit the Company's Web site at www.biocryst.com.

Forward-Looking Statements

This press release contains forward-looking statements, including statements regarding future results, performance or achievements. These statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Some of the factors that could affect the forward-looking statements contained herein include: that peramivir may not receive emergency use authorization; that the U.S. government may choose not to ship peramivir to the CDC Strategic National Stockpile; that to the extent peramivir is used as a treatment for H1N1 flu (or other strains of flu), there can be no assurance that it will prove effective; that HHS may further condition, reduce or eliminate future funding of the peramivir program; that ongoing peram
'/>"/>

SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. BioCryst Pharmaceuticals Announces Presentation of Forodesine Data at the 45th Annual Meeting of the American Society of Clinical Oncology
2. BioCryst to Present at the 11th Annual BIO CEO & Investor Conference
3. BioCryst Pharmaceuticals to Announce Fourth Quarter and Year End 2008 Financial Results on February 6, 2009
4. BioCryst to Present at the Rodman and Renshaw 10th Annual Healthcare Conference
5. BioCryst Reports Positive Results From a Phase 2 Study of Intravenous Peramivir for Outpatient Influenza
6. BioCryst Pharmaceuticals to Announce First Quarter 2008 Financial Results on May 8, 2008
7. BioCryst to Release Third Quarter 2007 Financial Results on Thursday, November 8, 2007
8. Encision Reports Profitable First Fiscal Quarter Results
9. Nutraceutical Reports Fiscal 2009 Q3 Results and Expands Share Repurchase Program
10. Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share
11. BioMed Realty Trust Reports Second Quarter 2009 Operating and Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... early April, senior leaders from medical, law enforcement, military, ... one question: how can first responders improve survival after ... results of this discussion are now available in " ... ," a concept paper published in the June issue ... Acute Care Surgery , official publication of the ...
(Date:6/19/2013)... body,s system for repairing damage to the genetic material ... it may seem, those compounds are sparking optimism as ... a mutation in BRCA, a gene that made headlines ... The compounds, termed PARP inhibitors, are the topic of ... Chemical & Engineering News . C&EN is the weekly ...
(Date:6/19/2013)... Ariz. (PRWEB) June 19, 2013 PREFERRED ... WellCare of Arizona to offer a new ... Maricopa, Pima, La Paz, Yavapai and Mohave, Arizona counties. ... Mohave counties were effective January 1, 2013 and Maricopa ... 2014. , WellCare, Inc., the parent company of WellCare ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Kansas City will host ... Main Street Day . A section of Main Street in ... during the afternoon of the event. The Main Street Corridor ... event, which will help Kansas City join the ranks of dozens ... as a tool to foster community vibrancy and active lifestyles. , ...
(Date:6/19/2013)... Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig,s ... be classified into four distinct stages, report pathologists with ... Pennsylvania in the Annals of Neurology . This ... shows, for the first time, how the fatal degenerative ... central nervous system to other regions of brain and ...
Breaking Medicine News(10 mins):Health News:Hartford consensus aims to improve survival after mass shootings 2Health News:PREFERRED Therapy Providers, Inc. and WellCare of Arizona Finalize Their Agreement to Offer Medicare Advantage Plan to PREFERRED's Arizona Provider Network 2Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 2Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 3Health News:Staging system in ALS shows potential tracks of disease progression, Penn study finds 2
... have led people to re-examine their lifestyles and spend ... it is time to get to the basics of ... start their families now, instead of waiting for security. ... growing number of couples who are consulting fertility experts. ...
... 17 Bertalan Mesko, medical blogger and health 2.0 ... EchoJournal, a video site designed to present echocardiology videos ... team of one of the most famous medical blogs, ... users of other video sharing sites, including easy uploading, ...
... no reason to stop birth control , , FRIDAY, April 17 ... regularly and take birth-control pills may result in less muscle ... differences between women taking "the pill" and those not taking ... this point, the finding, from a study scheduled for presentation ...
... The University of Pittsburgh has received a five-year, ... Fogarty International Center to train researchers in regions of ... grant, part of the center,s AIDS International Training and ... training site in Mozambique, where there are an estimated ...
... 25 HARRISBURG, Pa., April 17 Health Secretary ... their time to help communities prepare for and respond ... important efforts. "National Volunteer Week starts Sunday and is ... sharing their time, energy and expertise to make Pennsylvania ...
... a leading Clinical Research Organization, announces it will present ... for April 21-24, 2009, in Washington, D.C. Dr. Sabine ... PRA, will chair the session, while Mark Nelson Tyrrell, ... of stakeholders for risk mitigation strategies." The discussion will ...
Cached Medicine News:Health News:Family Cocooning in the Face of Recession Leads to Expanded Business for Bay Area Fertility Doctor - Dr. Danielle Lane 2Health News:The Pill May Limit Muscle Gains in Women 2Health News:Pitt receives $2.8 million to train HIV/AIDS researchers in Mozambique, Brazil and India 2Health News:PA Secretary of Health Recognizes Pennsylvania Volunteers; Urges Greater Citizen Involvement 2Health News:PRA International to Present Key Challenges for Safety Professionals at the World Drug Safety Congress: PRA Experts discussing REMS at Washington DC Conference 2
(Date:6/18/2013)... NEW YORK , June 18, 2013  Intercept ... stage biopharmaceutical company focused on the development and commercialization ... diseases, today announced the pricing of an underwritten public ... a public offering price of $33.01 per share.  In ... to purchase up to an additional 259,500 shares of ...
(Date:6/18/2013)... June 18, 2013  It has become apparent ... Seating and Mobility, a subsidiary company of The ... repair. This appears to be due to the ... field service employees.  (Logo: ... of these clients are complex mobility users with ...
(Date:6/18/2013)... , June 18, 2013 Unilife Corporation ("Unilife" ... designer, developer and manufacturer of injectable drug delivery systems, ... at www.unilife.com . The new site includes additional ... to occur on a regular basis. Mr. ... "As an emerging global leader for injectable drug delivery ...
Breaking Medicine Technology:Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2Unilife Launches New Corporate Website 2
Inquire...
The ACMI™ Operative Laparoscopy System is designed for single- and dual-incision CO2 laser procedures and is used with 45cm laparoscopic instruments....
Inquire...
Compact, economical Bactron II anaerobic environment system with air lock, workspace and a 200 plate capacity incubator delivers optimum productivity in a compact space....
Medicine Products: